Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Implantable prosthesis
Patent
1992-04-01
1994-05-24
Green, Randall L.
Prosthesis (i.e., artificial body members), parts thereof, or ai
Implantable prosthesis
623 66, 424422, 424424, 6048901, 6048911, A61F 202, A61K 922, A61J 100
Patent
active
053144716
ABSTRACT:
Implant assemblies and methodologies provide immuno-protection for implanted allografts, xenografts, and isografts. The assemblies and methodologies establish a boundary between the host and the implanted cells. The boundary has a pore size, an ultimate strength, and a metabolic transit value that assures the survival of the cells during the critical ischemic period and afterward. The boundary allows the fabrication and clinical use of implant assemblies and methodologies that can carry enough cells to be of therapeutic value to the host, yet occupy a relatively small, compact area within the host.
REFERENCES:
patent: 3967618 (1976-07-01), Zaffaroni
patent: 3993072 (1976-11-01), Zaffaroni
patent: 4011861 (1977-03-01), Enger
patent: 4266999 (1981-05-01), Baier
patent: 4298002 (1981-11-01), Ronel et al.
patent: 4306318 (1981-12-01), Mano et al.
patent: 4309776 (1982-01-01), Berguer
patent: 4309996 (1982-01-01), Theeuwes
patent: 4352883 (1982-10-01), Lim
patent: 4353888 (1982-10-01), Sefton
patent: 4374669 (1983-02-01), Mac Gregor
patent: 4378016 (1983-03-01), Loeb
patent: 4391909 (1983-07-01), Lim
patent: 4475916 (1984-10-01), Himmelstein
patent: 4487758 (1984-12-01), Goosen et al.
patent: 4508113 (1985-04-01), Malaney
patent: 4542539 (1985-09-01), Rowe, Jr. et al.
patent: 4553272 (1985-11-01), Mears
patent: 4576608 (1986-03-01), Homsy
patent: 4601893 (1986-07-01), Cardinal
patent: 4657544 (1987-04-01), Pinchuk
patent: 4664669 (1987-05-01), Ohyabu
patent: 4670286 (1987-06-01), Nyilas et al.
patent: 4673566 (1987-06-01), Goosen et al.
patent: 4686098 (1987-08-01), Kopchick et al.
patent: 4689293 (1987-08-01), Goosen et al.
patent: 4712553 (1987-12-01), MacGregor
patent: 4743252 (1988-05-01), Martin, Jr. et al.
patent: 4795459 (1989-01-01), Jauregui
patent: 4798585 (1989-01-01), Inoue et al.
patent: 4803168 (1989-02-01), Jarvis, Jr.
patent: 4804381 (1989-02-01), Turina et al.
patent: 4806355 (1989-02-01), Goosen et al.
patent: 4816339 (1989-03-01), Tu et al.
patent: 4871366 (1989-10-01), von Recum et al.
patent: 4877029 (1989-10-01), Valentini et al.
patent: 4878913 (1989-11-01), Aebischer et al.
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 4911717 (1990-03-01), Gaskill, III
patent: 4922926 (1990-05-01), Hirschberg et al.
patent: 4936317 (1990-06-01), MacGregor
patent: 4950483 (1990-08-01), Ksander et al.
patent: 4990138 (1991-02-01), Bacich et al.
patent: 5002661 (1991-03-01), Chick et al.
patent: 5024670 (1991-06-01), Smith et al.
patent: 5077215 (1991-12-01), McAuslan et al.
patent: 5182111 (1993-01-01), Aebischer et al.
"Macroporous Hydrogel Members for a Hybrid Artificial Pancreas. II. Biocompatibility", G. Klomp et al., Journal of Bio. Mat. Rsch., vol. 17, 865-871 (1983).
"Bioengineering in Development of the Hybrid Artificial Pancreas", C. K. Colton et al., Journal of Biomechanical Engineering, vol. 113, May, 1991.
"Macrophage-derived Growth Factors in Wound Healing: Regulation of Growth Factor Production by the Oxygen Microenvironment", D. Knighton et al., Am. Rev. Respir. Dis. 1989; 140:1108-1111.
"Activated Macrophages Induce Vascular Proliferation", Polverini et al., Nature, vol. 269, Oct. 27, 1977.
"Oxygen Tension Regulates the Expression of Angiogenesis Factor by Macrophages", Knighton et al., Science, vol. 221, Sep. 8, 1981.
"Texturing of Polymer Surfaces at the Cellular Level", Schmidt et al., Biomaterials, vol. 12, May, 1991.
"Microtopography and Soft Tissue Response", Campbell et al., Journal of Investigative Surgery, vol. 2, pp. 51-74, 1989.
"Inflammatory Response to Implants" by James M. Anderson. vol. XXXIV Trans Am Soc Artif Intern Organs 1988, pp. 101-107.
"Microtopography and Soft Tissue Response"by Craig Campbell et al. Journal of Investigative Surgery, vol. 2, pp. 51-74, 1989.
"Tissue Reaction to Intraperitoneal Polymer implants: Species Difference and Effects of Corticoid and Doxorubicin" by L. Christineson et al. Journal of Biomedical Materials Research, vol. 23, pp. 705-718, 1989.
"Islet Immuno-isolation; The Use of Hybrid Artificial Organs to Prevents Islet Rejection", World J. Surg. 8, 221-229, 1984. D. Scharp et al.
"Characterization of Biomedical Polymeradherent Macrophages: Interlukin 1 Generation and Scanning Electron Microscopy Studies". Biomaterials 1989. vol. 10 Apr., pp. 187-196. K. M. Miller et al.
"The Tissue Response to Implants and Its Evaluation by Light Microscopy" A. von Recum, Soft Tissue Histology pp. 364-378.
Boggs Daniel R.
Brauker James H.
Hill Ronald S.
Johnson Robert C.
Martinson Laura A.
Bates Sarah E.
Baxter International Inc.
Flattery Paul C.
Green Randall L.
Hguyen Dinh X.
LandOfFree
Tissue inplant systems and methods for sustaining viable high ce does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tissue inplant systems and methods for sustaining viable high ce, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tissue inplant systems and methods for sustaining viable high ce will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1970145